Key result
Intravenous delivery of TNF-α shRNA via PDAPEI significantly reduced the clinical arthritis severity score to 0.2 compared to 2.5 in the saline control group in a murine model of rheumatoid arthritis.
Why the study?
Does PDAPEI delivering TNF-α shRNA reduce the severity of arthritis in a murine model of rheumatoid arthritis?
Does PDAPEI delivering TNF-α shRNA reduce the severity of arthritis in a murine model of rheumatoid arthritis?
Absolute Event Rate: 0.2% vs 2.5%
p-value: p=<0.01
PDAPEI is an efficient and non-toxic carrier for delivering TNF-α shRNA, showing potential for treating rheumatoid arthritis in a murine model.
May warrant further preclinical testing; leaves open clinical translation of PDAPEI-mediated TNF-α shRNA delivery.
Small interfering RNA (siRNA) is an effective and specific method for silencing genes. However, an efficient and non-toxic carrier is needed to deliver the siRNA into the target cells. Tumor necrosis factor α (TNF-α) plays a central role in the occurrence and progression of rheumatoid arthritis (RA). In this study, we pre-synthetized a degradable cationic polymer (PDAPEI) from 2,6-pyridinedicarboxaldehyde and low-molecular-weight polyethyleneimine (PEI, Mw = 1.8 kDa) as a gene vector for the delivery of TNF-α shRNA. The PDAPEI/pDNA complex showed a suitable particle size and stable zeta potential for transfection. In vitro study of the PDAPEI/pDNA complex revealed a lower cytotoxicity and higher transfection efficiency when transfecting TNF-α shRNA to macrophages by significantly down-regulating the expression of TNF-α. Moreover, the complex was extremely efficient in decreasing the severity of arthritis in mice with collagen-induced arthritis. PDAPEI delivered TNF-α shRNA has great potential in the treatment of RA.
No takes yet. Share an insight, caveat, or question.
Song et al. (2016) studied Rheumatoid arthritis (murine model) (n=24). PDAPEI/pDNA complex (TNF-α shRNA) vs. Saline was evaluated on Clinical arthritis severity score (p=<0.01). Intravenous delivery of TNF-α shRNA via PDAPEI significantly reduced the clinical arthritis severity score to 0.2 compared to 2.5 in the saline control group in a murine model of rheumatoid arthritis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: